Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05113979 · ClinicalTrials.gov registry record
Early Feasibility Study to Evaluate the AccuraSee in Correcting Residual Refractive Errors After Cataract Surgery
A clinical trial of Refractive Errors, sponsored by OnPoint Vision.
- Completed
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT05113979: Completed study of Refractive Errors, sponsored by OnPoint Vision.
NCT05113979 is a study of Refractive Errors that has completed, run by OnPoint Vision. The registered enrollment target is 10 participants, below the 106-participant average among 14 other Refractive Errors trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05113979, a study of Refractive Errors, has completed, sponsored by OnPoint Vision.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine if the intraocular pseudophakic contact lens (IOPCL), referred to as the AccuraSee, corrects residual refractive errors after cataract surgery using a plus powered lens in subjects with ocular pathology previously implanted with a Bausch and Lomb LI61AO or LI61SE monofocal posterior chamber intraocular lens (PCIOL) and to confirm its positional stability and adherence relative to the PCIOL.
Primary Outcome
Proportion of subjects (≥ 50%) able to achieve MRSE stability within ±0.5D within two consecutive postoperative visits at 1 month or later visits.
Conditions Studied
Interventions
- DEVICE AccuraSee IOPCL with +3.0D add
Study Locations (1)
Minnesota
- Chu Vision Institute - Bloomington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-03-09 |
| Est. Completion | 2022-09-09 |
What the finished NCT05113979 record still lists
NCT05113979 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 106-participant average among 14 other Refractive Errors trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Refractive Errors appearing as the primary indexed condition, and to 1 intervention - of which AccuraSee IOPCL with +3.0D add is the first listed.
NCT05113979 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05113979 about?
NCT05113979 is a clinical study titled "Early Feasibility Study to Evaluate the AccuraSee in Correcting Residual Refractive Errors After Cataract Surgery". To determine if the intraocular pseudophakic contact lens (IOPCL), referred to as the AccuraSee, corrects residual refractive errors after cataract surgery using a plus powered lens in subjects with ocular pathology previously implanted with a Bausch and Lomb LI61AO or LI61SE monofocal posterior cha...
What is the current status of trial NCT05113979?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2020-03-09. Estimated completion is 2022-09-09.
What conditions does trial NCT05113979 study?
This clinical trial studies the following conditions: Refractive Errors.
What interventions are being tested in trial NCT05113979?
The interventions under investigation include: AccuraSee IOPCL with +3.0D add (DEVICE).
Who is sponsoring clinical trial NCT05113979?
This trial is sponsored by OnPoint Vision, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05113979 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Refractive Errors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05113979's enrollment target sits among peer trials
10 15th of 14 the lowest of 14 other Refractive Errors trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Refractive Errors trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
To Study the Effects of Refractive Surgery on OCT Measurements in the Eye
RECRUITING
-
Corneal Elastography and Patient Specific Modeling
RECRUITING
-
Clinical Performance of a Silicone Hydrogel Contact Lens Following One Night of Extended Wear
COMPLETED · NA
-
Clinical Performance of Two Commercial, Daily Disposable Contact Lenses
COMPLETED · NA
-
Clinical Performance of a Monthly Replacement Silicone Hydrogel Lens
COMPLETED · NA
-
Investigation of the Accuracy of an Automated Refractor to Provide Well-tolerated Eyeglass Prescriptions
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI